Roaring Waters Capital has increased its holding in Poolbeg Pharma, lifting its voting rights to 6.55%. The investor previously held 5.74% of Poolbeg’s voting rights.
Poolbeg Pharma Advances POLB 001 Patent Protection in Israel
Poolbeg Pharma (AIM: POLB) has received a Notice of Allowance from the Israeli Patent Office for its POLB 001 patent application covering cancer immunotherapy-induced Cytokine Release Syndrome.
Share Talk Weekly Stock Market News Review, Sunday 19th July 2026
London’s FTSE 100 outperformed global peers on Friday as defensive utilities and energy stocks helped offset wider market weakness driven by a sell-off in technology and semiconductor shares. The blue-chip
RNS Hotlist with Zak Mir: POLB, ROCK, IRON, SYS, CLBX, SOS, HERC, SWG & PYC
Poolbeg Pharma Plc (POLB), a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, is pleased to announce that it has raised £3.5 million (before expenses) pursuant to a placing
Poolbeg Pharma Raises £3.5m as Cathal Friel Invests £250,000
Poolbeg Pharma Plc (AIM: POLB) has raised £3.5 million before expenses through the placing of 58,333,328 new shares at 6p each.
First patient dosed in POLB 001 TOPICAL trial
First Patient Dosed in the POLB 001 TOPICAL Clinical Trial Interim data remains on track for summer 2026 and partnering discussions continue to advance with multiple companies
RNS Hotlist with Zak Mir: TGR, KEFI, CLA, NEO, KEN, RENX, MTEC, OBI, RIFT, POLB, SWC, CBOX & BMIN
Total Graphite (TGR): Optiva Research issued a research report on the fast improving mining group. previously Tirupati Graphite PLC – has recently undergone significant corporate change which has put it on
South African approval boosts POLB intellectual property
POLB 001 patent granted in South Africa for the treatment or prevention of hypercytokinemia and severe influenza Patent decision strengthens Poolbeg’s intellectual property portfolio
Share Talk Weekly Stock Market News Review, Sunday 21st June 2026
UK stocks ended the week on a weaker footing. The FTSE 100 fell 0.4% to close at 10,363, leaving the blue-chip index down 1.0% for the week — its steepest
RNS Hotlist with Zak Mir: GLR, CIZ, GANA, PR1, IHC, MDZ, AEG, POLB, DEBS, CTL & TAM
Galileo Resources plc (GLR) announced that on 15 June 2026 it entered into a conditional share purchase agreement with Metal Capital Exploration Limited, a wholly owned subsidiary of ASX-listed Sandfire Resources
Poolbeg Pharma (AIM: POLB) European patent granted for POLB 001 in CRS
Decision to grant European Patent received for POLB 001 in cancer immunotherapy-induced CRS Major milestone will provide IP protection in key European markets, strengthening global patent portfolio
Share Talk Weekly Stock Market News Review, Sunday 14th June 2026
UK equities rallied strongly on Friday as investors responded positively to growing optimism that a diplomatic agreement between the United States and Iran could be within reach, easing concerns over